101. Erbstatin blocks platelet activating factor-induced protein-tyrosine phosphorylation, polyphosphoinositide hydrolysis, protein kinase C activation, serotonin secretion and aggregation of rabbit platelets
- Author
-
Sandra Howard, Hassan Salari, Vincent Duronio, Alan Thomas Hudson, Anne Reany, Kelvin E. Jones, Steven L. Pelech, and Michelle Demos
- Subjects
Blood Platelets ,Serotonin ,(Platelet) ,Platelet Aggregation ,Biophysics ,In Vitro Techniques ,Phosphatidylinositols ,Biochemistry ,Serotonin secretion ,Antibodies ,chemistry.chemical_compound ,Protein phosphorylation ,Phosphatidylinositol Phosphates ,Structural Biology ,Genetics ,Animals ,Platelet ,Phosphorylation ,Platelet Activating Factor ,Phosphotyrosine ,Molecular Biology ,Protein kinase C ,Protein Kinase C ,Erbstatin ,Platelet-activating factor ,Hydrolysis ,Tyrosine phosphorylation ,Cell Biology ,Protein-Tyrosine Kinases ,Hydroquinones ,Enzyme Activation ,Kinetics ,chemistry ,Phosphatidylinositol turnover ,Tyrosine ,Rabbits ,Signal transduction ,Platelet Aggregation Inhibitors - Abstract
The role of protein-tyrosine phosphorylation in the signal transduction of platelet activating factor (PAF) was investigated in rabbit platelets with a range of synthetic compounds that inhibit protein-tyrosine kinases. In particular, erbstatin (IC50 approximately 20 micrograms/ml) abrogated a wide range of platelet responses to PAF, including tyrosine phosphorylation of cellular proteins, polyphosphoinositide turnover, activation of membranous protein kinase C, platelet aggregation, and serotonin secretion. With about a third of the potency of erbstatin, compound RG50864 also inhibited many of these responses, whereas at 100 micrograms/ml, genistein, 670C88 and ST271 were without effect. Finally, the ability of thrombin to cause platelet aggregation and serotonin secretion was also compromised by erbstatin.
- Full Text
- View/download PDF